# B3GNT4

## Overview
B3GNT4 is a gene that encodes the enzyme UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, a transmembrane glycosyltransferase located in the Golgi apparatus. This enzyme plays a critical role in the glycosylation process by catalyzing the transfer of N-acetylglucosamine to galactose-containing substrates, which is essential for the elongation and branching of O-linked oligosaccharide chains in mucin glycoproteins. These glycoproteins are vital for maintaining mucosal barrier functions, particularly in the intestine, and their dysfunction is linked to diseases such as colitis and colorectal cancer (Rao2022Genomic). The enzyme's activity is crucial for maintaining cellular homeostasis by preserving LacNAc content within N-glycans and supporting the galectin-glycoprotein lattice, which prevents T cell hyperactivity (Mkhikian2016Golgi). B3GNT4 is also implicated in cancer prognosis, serving as a potential biomarker for poor outcomes in cancer patients due to its involvement in the biosynthesis of glycan structures on cell surfaces (Pucci2022Glycosyltransferases).

## Function
B3GNT4 is a gene that encodes a transmembrane Golgi enzyme involved in the glycosylation process, specifically catalyzing the transfer of N-acetylglucosamine from UDP-GlcNAc onto galactose-containing substrates. This enzymatic activity is crucial for the elongation and branching of O-linked oligosaccharide chains of mucin glycoproteins, which are essential for the complete functional maturation of mucins. Mucins play pivotal roles in mucosal barrier functions in the intestine, and their dysfunction is associated with conditions such as colitis and colorectal cancer (Rao2022Genomic).

The enzyme is active in the Golgi apparatus, where it contributes to the production of bioequivalent poly-LacNAc containing glycans. This process is part of a self-correcting mechanism that maintains cellular homeostasis by ensuring LacNAc content is preserved within N-glycans. The B3GNT4 enzyme, along with other members of the B3GNT family, helps maintain cell surface LacNAc density and the galectin-glycoprotein lattice, which is crucial for cellular homeostasis and preventing T cell hyperactivity (Mkhikian2016Golgi).

B3GNT4's activity in the Golgi apparatus influences cellular and organismal functions such as immune response and development, highlighting its importance in maintaining the integrity of the glycome and cellular communication networks.

## Clinical Significance
B3GNT4 is a glycosyltransferase gene implicated in cancer prognosis. It is categorized as a 'Bad Prognosis-associated' (BPA) gene, with a BPA score of 5, indicating a strong association with poor outcomes in cancer patients (Pucci2022Glycosyltransferases). This suggests that alterations in B3GNT4 expression or function may contribute to cancer progression and could serve as a prognostic biomarker. The enzyme encoded by B3GNT4 is involved in the biosynthesis of type 2 polylactosaminic chains, which are important for glycan structures on cell surfaces (Pucci2022Glycosyltransferases).

In the context of thymoma, B3GNT4 is part of the glycosphingolipid biosynthesis pathway, although its specific clinical significance in this cancer type is not well-documented. It shows strong correlations with other genes in the pathway, such as FUT1, but its direct impact on survival outcomes in thymoma patients remains unclear (Zhang2023Role).

Overall, while B3GNT4 is recognized for its role in cancer prognosis, detailed insights into its mutations, expression levels, and specific interactions in various diseases are limited, highlighting the need for further research to elucidate its clinical significance.


## References


[1. (Zhang2023Role) Xin Zhang, Bo Zeng, Haoshuai Zhu, Rui Ma, Ping Yuan, Zhenguang Chen, Chunhua Su, Zhihao Liu, Xiaojing Yao, Aurora Lawrence, Zhenguo Liu, and Jianyong Zou. Role of glycosphingolipid biosynthesis coregulators in malignant progression of thymoma. International Journal of Biological Sciences, 19(14):4442–4456, 2023. URL: http://dx.doi.org/10.7150/ijbs.83468, doi:10.7150/ijbs.83468. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijbs.83468)

[2. (Rao2022Genomic) Chinthalapally V. Rao, Chao Xu, Yuting Zhang, Adam S. Asch, and Hiroshi Y. Yamada. Genomic instability genes in lung and colon adenocarcinoma indicate organ specificity of transcriptomic impact on copy number alterations. Scientific Reports, July 2022. URL: http://dx.doi.org/10.1038/s41598-022-15692-8, doi:10.1038/s41598-022-15692-8. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-15692-8)

[3. (Pucci2022Glycosyltransferases) Michela Pucci, Martina Duca, Nadia Malagolini, and Fabio Dall’Olio. Glycosyltransferases in cancer: prognostic biomarkers of survival in patient cohorts and impact on malignancy in experimental models. Cancers, 14(9):2128, April 2022. URL: http://dx.doi.org/10.3390/cancers14092128, doi:10.3390/cancers14092128. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers14092128)

[4. (Mkhikian2016Golgi) Haik Mkhikian, Christie-Lynn Mortales, Raymond W Zhou, Khachik Khachikyan, Gang Wu, Stuart M Haslam, Patil Kavarian, Anne Dell, and Michael Demetriou. Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis. eLife, June 2016. URL: http://dx.doi.org/10.7554/elife.14814, doi:10.7554/elife.14814. This article has 68 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.14814)